RItuximab Versus FUmarate in Newly Diagnosed Multiple Sclerosis.

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2016
A randomized phase 3 study comparing Rituximab with Dimethyl Fumarate in early Relapsing-Remitting Multiple Sclerosis and Clinically Isolated Syndrome.
Epistemonikos ID: bc9fe6b8f36e209c2afd385a5c8b34c2519e0097
First added on: Mar 31, 2022